<ul class="summary-bullets"><li>The therapy also demonstrated encouraging efficacy with changes that resulted in improved laboratory markers for the disease and the resolution of anemia, the company said.&nbsp;</li><li>Beam is now looking to make an application seeking the U.S. Food and Drug Administration’s approval for the therapy as early as 2026 year-end.</li></ul>Shares of Beam Therapeutics (BEAM) rallied 3% after hours on Wednesday after the company said that its clinical trial evaluating ristoglogene autogetemcel for the treatment of sickle cell disease (SCD) with severe vaso-occlusive crises demonstrated encouraging efficacy.The company said that risto-cel, its investigational genetically modified cell therapy, demonstrated an acceptable safety profile and encouraging efficacy with changes that resulted in improved laboratory markers for the disease and the resolution of anemia. The data from the trial was published in the The New England Journal of Medicine.Sickle cell disease (SCD) is a group of inherited blood disorders caused by a genetic mutation leading to abnormal hemoglobin, which causes red blood cells to become rigid, sickle-shaped, and prone to breaking down. SCD with severe vaso-occlusive crises (VOC) involves sickle-shaped red blood cells blocking blood flow, causing intense, often bone-deep pain, ischemia, and organ damage.“Based on the totality of data generated to date from the BEACON study and the optimized treatment and manufacturing process, we believe risto-cel has the potential to be best-in-class. With an estimated 10,000 patients with SCD in the U.S. eligible for gene therapies, and significant demand expected as these treatments become more widely available, risto-cel is well positioned within this growing market,” said Amy Simon, chief medical officer of Beam.Beam is now looking to make an application seeking the U.S. Food and Drug Administration’s approval for the therapy as early as 2026 year-end. The FDA previously granted risto-cel orphan drug designation and Regenerative Medicine Advanced Therapy (RMAT) designation.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around BEAM stock fell from ‘bullish’ to ‘neutral’ territory over the past 24 hours, while message volume fell from high to normal levels.<a href="https://stocktwits.com/symbol/BEAM">BEAM stock</a> has gained 37% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-agpu-stock-rise-today/cZ7HyVtRIF0">Why Did AGPU Stock Rise 120% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Beam Therapeutics logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Why Is BEAM Stock Edging Higher After Hours Today?

The company said that risto-cel, its investigational genetically modified cell therapy, demonstrated an acceptable safety profile in a trial. 

Equity

Shares of Globalstar (GSAT) soared 20% after hours on Wednesday following reports that Amazon is in talks to acquire the company.Financial Times reported on Wednesday that the online retailer is in talks to acquire Globalstar in a bid to build its own network of satellites in low Earth orbit. The two companies are negotiating over deal complexities after lengthy talks, the report said.However, no deal has been finalised and the talks could collapse without an agreement, the report added.&nbsp;Get updates to this developing story directly on Stocktwits. &nbsp;

 In this photo illustration, a Globalstar company logo is seen displayed on a smartphone screen.

GSAT Stock Soars After Hours On Reports Of Buyout Talks With Amazon

Financial Times reported on Wednesday that the online retailer is in talks to acquire Globalstar in a bid to build its own network of satellites in low Earth orbit. 

<ul class="summary-bullets"><li>PENG said it expects adjusted net sales for fiscal year 2026 of 12% year-over-year growth +/-5%.&nbsp;</li><li>It expects adjusted diluted earnings per share of $2.15 +/- $0.15 for FY26.&nbsp;</li></ul>Penguin Solutions (PENG) shares rallied 14% in Wednesday’s extended hours of trading as it reported its second quarter net sales that was above analyst estimates.&nbsp;“Enterprises, governments, and neocloud providers are racing to build AI factories, as platforms scale to power the next generation of inference workloads,” said Kash Shaikh, CEO of Penguin Solutions. “Our AI/HPC pipeline continues to expand, and we added five AI/HPC customers this quarter, including a Tier One financial institution deploying our MemoryAI™ CXL-based KV cache server.&nbsp;“Memory is a critical scaling factor for AI inference, and that aligns with one of our core strengths. Reflecting strong memory demand and disciplined execution, we are raising our full-year net sales and EPS outlook,” Shaikh added.&nbsp;<h2 class="st-heading-2">Details</h2>PENG reported net sales for the second quarter of $343 million, down 6% versus the year-ago quarter, but was above analysts’ estimates of $339 million as per data from Stocktwits data.&nbsp;It reported adjusted diluted earnings per share of $0.52 for the second quarter, flat year-over-year. The adjusted profit was well above average analysts’ projection of $0.42 per share, as per data from Stocktwits. PENG reported its gross margin of 31.2%, up 40 basis points versus the year-ago quarter<h2 class="st-heading-2">Outlook</h2>PENG said it expects adjusted net sales growth of 12% year-over-year +/-5%&nbsp; for fiscal year 2026.&nbsp;&nbsp;It expects adjusted diluted earnings per share of $2.15, +/- $0.15 for the period.&nbsp;<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around PENG trended in ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;One bullish user predicted that PENG stock will ‘explode’.<stembedurl>https://stocktwits.com/Thrasher5699/message/649224359</stembedurl>Another user praised the company’s performance in the quarter.&nbsp;<stembedurl>https://stocktwits.com/RazorbackAJ/message/649221276</stembedurl>Shares in the company are down 8% so far in 2026.&nbsp;&nbsp;

PENG said it expects adjusted net sales growth of 12% year-over-year +/-5%  for fiscal year 2026.  

PENG Stock Rallying 14% After Hours – What’s Behind The Bull Run?

PENG reported its net sales for the second quarter of $343 million, above $339 million as per data from Stocktwits data.

<ul class="summary-bullets"><li>The deals, spread across more than 20 enterprise customers, are expected to generate approximately $7.5 million in revenue for the remainder of 2026.</li><li>The company currently has more than 30 active deployments spanning AI-native startups and established enterprises.</li></ul>&nbsp;Shares of Axe Compute Inc. (AGPU) closed 120% higher on Wednesday and edged up 19% after hours after the company said that it has signed deals worth about $12 million in total in the last 30 days, setting the stage for an estimated $835,000 in monthly recurring income as the company enters the second quarter.The deals, spread across more than 20 enterprise customers, are expected to generate approximately $7.5 million in revenue for the remainder of 2026 based on the current monthly run rate. The company currently has more than 30 active deployments spanning AI-native startups and established enterprises, with GPU hardware ranging from NVIDIA RTX 5090s to H100, H200 and B200 architectures.“This is not a marketing milestone — it is executed agreements from enterprises with production AI workloads,” said Chris Miglino, chief executive officer of Axe Compute. “Every agreement signed strengthens the foundation of the business. This is the beginning of our income from our GPU business and we are excited for this growth.”<h2 class="st-heading-2">About Axe Compute</h2>Axe Compute structures its enterprise contracts with monthly payments made in advance against reserved capacity, a model designed to minimize receivables risk and deliver predictable cash flow. The company says the payment terms reflect customer confidence in its ability to deliver reliable infrastructure quickly.The company positions itself as the enterprise GPU marketplace, giving AI innovators and enterprises access to any GPU architecture in any of 200+ global locations, deployed in as little as 24-48 hours. It was called Predictive Oncology until December and then renamed itself as part of its transformation to AI compute infrastructure. &nbsp;Earlier this week, the company reported full year total revenue of $125,284, derived entirely from the company’s drug discovery services legacy segment, and net loss from continuing operations of $232.9 million.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around AGPU stock rose from ‘bullish’ to ‘extremely bullish’ over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.A Stocktwits user expressed optimism over the pace at which the company landed GPU agreements.<stembedurl>https://www.stocktwits.com/Shake_Daddy/message/649223855</stembedurl>Another said that the pivot into AI compute is “working very well.”<stembedurl>https://www.stocktwits.com/Cpt_Sergio/message/649223370</stembedurl><a href="https://stocktwits.com/symbol/AGPU">AGPU stock</a> &nbsp;has lost 84% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/alto-neuroscience-schizophrenia-study-fails/cZ7HygQRIFi">ANRO Stock On Investors’ Radar After Failed Schizophrenia Study Results</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Did AGPU Stock Rise 120% Today?

The company signed deals worth $12 million, setting the stage for income from its new compute segment.

<ul class="summary-bullets"><li>Alto will now focus on its other programs including ALTO-207 in development for treatment -resistant depression.</li><li>The company said that it also intends to explore partnering opportunities for a modified-release oral formulation of ALTO-101 that it has developed.</li></ul>Shares of Alto Neuroscience, Inc. (ANRO) fell as much as 10% after hours on Wednesday after the company said that its experimental drug for the treatment of schizophrenia failed to achieve statistical significance on key goals in a mid-stage study.The company was studying ALTO-101 for the treatment of cognitive impairment associated with schizophrenia. However, no statistically significant changes were detected on primary electroencephalography or cognitive endpoints as compared to placebo, the company said.<h2 class="st-heading-2">Plans Ahead</h2>As a result, the company does not intend to independently advance ALTO-101 in CIAS anymore, it said, while adding that it would now focus on its other programs including ALTO-207 in development for treatment -resistant depression. Alto is looking to initiate a mid-stage trial for &nbsp;ALTO-207 in the first half of 2026. &nbsp;The company said that it now intends to explore partnering opportunities for a modified-release oral formulation of ALTO-101 that it has developed. The formulation has demonstrated an improved pharmacokinetic and tolerability profile when compared to the immediate-release formulation, Alto said, while adding that it believes the formulation may offer potential benefits across several therapeutic areas.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around ANRO &nbsp;stayed within the ‘bearish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels.A Stocktwits user noted the company’s balance sheet, terming it an “easy short.”<stembedurl>https://www.stocktwits.com/Shortski/message/649224122</stembedurl>The company said earlier this month that it had cash, cash equivalents, and restricted cash of approximately $177 million as of the end of 2025, expected to support its planned operations into 2028.Another user termed the selloff an “overreaction.”<stembedurl>https://www.stocktwits.com/RazorbackAJ/message/649224026</stembedurl> <a href="https://stocktwits.com/symbol/ANRO">ANRO stock</a> has gained 32% this year.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-agpu-stock-rise-today/cZ7HyVtRIF0">Why Did AGPU Stock Rise 120% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Alto Neuroscience logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

ANRO Stock Falls After Hours On Failed Schizophrenia Study Results

Alto Neuroscience does not intend to independently advance ALTO-101 in CIAS anymore, it said. 

<ul class="summary-bullets"><li>Apple confirmed Blahnik’s retirement to the newspaper.&nbsp;</li><li>The high-profile executive was a key figure in the company’s expansion into fitness technology and services.</li><li>Blahnik joined Apple in 2013 and played a key role in developing the Apple Watch’s signature fitness features.</li></ul>Apple’s vice president of fitness technologies, Jay Blahnik, is reportedly retiring this summer after a nearly 13-year tenure at the technology giant.&nbsp;In an email to employees this week, Apple said Blahnik, 57, will retire in July “to spend time with his family and make an exciting move to New York City, according to the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.nytimes.com/2026/04/01/technology/apples-fitness-chief-who-was-accused-of-harassment-is-retiring.html">New York Times</a>.&nbsp;Blahnik’s career was marred by several controversies and accusations that included that he created a toxic workplace culture and sexually harassed an employee, as per the report. Blahnik was described by current and former employees as verbally abusive, manipulative and inappropriate, The New York Times previously reported. Since 2022, more than 10 of the roughly 100 employees on his team sought extended mental health or medical leaves of absence.Apple confirmed Blahnik’s retirement to the newspaper.&nbsp;<h2 class="st-heading-2">His Contribution</h2>The high-profile executive was a key figure in the company’s expansion into fitness technology and services.Blahnik joined Apple in 2013 and played a key role in developing the Apple Watch’s signature fitness features. He later led the Fitness+ subscription service, which offers video and audio workouts for activities like cycling, meditation, and yoga.Before joining Apple, Blahnik was a well-known fitness expert and author, having spent 20 years working with Nike. He is credited with designing the Apple Watch’s hallmark fitness feature: three rings users can close each day by exercising, standing, and burning calories.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around AAPL trended in ‘extremely bullish’ territory amid ‘high’ message volume.&nbsp;Shares in the company are down 6% so far in 2026.&nbsp;&nbsp;

A new Apple Watch is displayed during an Apple special event at Apple headquarters on September 9, 2025 in Cupertino, California.  

Apple’s VP Of Fitness Tech Jay Blahnik Is Reportedly Retiring 

 In an email to employees this week, Apple said Blahnik, 57, will retire in July “to spend time with his family and make an exciting move to New York City, according to the New York Times. 

<ul class="summary-bullets"><li>The smelter on the outskirts of Abu Dhabi lost power due to the strikes and smelting facilities known as potlines were forced into an uncontrolled shutdown, the report said.&nbsp;</li><li>According to Bloomberg, aluminum prices rose as much as 2% on the London Metal Exchange.&nbsp;</li></ul>Aluminum stocks including Alcoa (AA), Kaiser Aluminum (KALU), and Century Aluminum (CENX) rallied on Wednesday after reports that Emirates Global Aluminium has halted operations.&nbsp;The Middle East's top producer of the metal halted operations at its Al Taweelah smelter after the site was struck by Iranian missiles and drones over the weekend, Bloomberg News reported, citing a person familiar with the matter.&nbsp;The smelter on the outskirts of Abu Dhabi lost power due to the strikes and smelting facilities known as potlines were forced into an uncontrolled shutdown, the report said.&nbsp;<h2 class="st-heading-2">Rising Aluminum</h2>Aluminum prices rose as much as 2% on the London Metal Exchange, the report said.&nbsp;LME futures for aluminum have soared following the strikes, and Aluminium Bahrain—another leading producer in the area—has also reported that its facilities were attacked by Iran over the weekend. Both plants rank among the largest globally,&nbsp;each having produced 1.6 million tons of aluminum in 2025, according to Bloomberg.Latest Analyst RationalesJPMorgan also earlier upgraded Alcoa to ‘Neutral’ from ‘Underweight’ with a price target of $68, up from $50. Since the conflict in Iran began, aluminum prices have rallied 12% on regional supply risk, the analyst then told investors in a research note.JPMorgan analyst Bill Peterson late in Feb. also raised the firm's price target on Kaiser Aluminum to $124 from $118 and kept a ‘Neutral’ rating on the shares.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around AA and CENX trended in ‘extremely bullish’ territory while sentiment for KALU trended in ‘bullish’ territory.&nbsp;Shares of AA, KALU and CENX gained 32%, 11.5% and 57.5%, respectively, so far this year.&nbsp;

A worker prepares to load aluminum alloy rods onto a truck at the workshop of an aluminum product manufacturing enterprise on May 13, 2025 in Binzhou, Shandong Province of China. (Photo by Chu Baorui/VCG via Getty Images)

Why Are Aluminum Stocks AA, KALU, CENX Rallying Today?

The Middle East's top producer of the metal halted operations at its Al Taweelah smelter after the site was struck by Iranian missiles and drones over the weekend, Bloomberg News reported.

<ul class="summary-bullets"><li>According to the report, the discussions are focused on an idled Stellantis assembly plant in Ontario.</li><li>Stellantis has a joint venture with Leapmotors aimed at expanding affordable electric vehicle sales globally outside Greater China.</li><li>Earlier today, Stellantis also reported that its first-quarter U.S. sales increased 4% versus the same period in 2025 to touch 305,902 units.</li></ul> Jeep maker Stellantis NV (STLA) is reportedly discussing making electric vehicles with its Chinese partner Zhejiang Leapmotor Technology Co. in Canada.Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-04-01/stellantis-in-talks-to-make-chinese-evs-at-idled-canadian-plant">reported</a> on the early stage talks on Wednesday, citing people familiar with the matter. According to the report, the discussions are focused on an idled Stellantis assembly plant in Ontario. The plant in Brampton was previously expected to produce a Jeep sport utility vehicle but after U.S. President Trump announced tariffs on foreign-made vehicles, Stellantis moved its production to the U.S., leaving it idle for longer.Stellantis has a joint venture with Leapmotors called Leapmotor International, established to expand affordable electric vehicle sales globally outside Greater China.<h2 class="st-heading-2">Tariffs And Deals</h2>The talks follow Canada’s agreement with Chinese President Xi Jinping in January to reduce tariffs on China-made electric vehicles in the aftermath of President Trump imposing hefty tariffs on foreign made cars and trucks imported into the U.S.If the talks proceed to action, it would be the first major Chinese auto investment in Canada since the country’s deal with China, Bloomberg said.<h2 class="st-heading-2">Stellantis US Sales</h2>Earlier today, Stellantis also reported that its first-quarter U.S. sales increased 4% versus the same period in 2025 to touch 305,902 units.&nbsp; The company recorded sales growth across its Ram, Jeep, and Dodge brands. The Chrysler Pacifica total sales increased nearly 84% month-over-month in March, marking the second consecutive month of growth, the company said.STLA stock traded 5% higher at the time of writing.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around STLA stock jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume remained at ‘normal’ levels.<a href="https://stocktwits.com/symbol/STLA">STLA stock</a> has lost 33% over the past 12 months.Read More: <a href="https://stocktwits.com/news-articles/markets/equity/uncy-retail-buzz-explodes-this-week-as-traders-bet-big-on-experimental-drug-approval/cZ7HuN1RIFf">UNCY Retail Buzz Explodes 150% This Week as Traders Bet Big on Experimental Drug Approval</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

General view of Stellantis logo on the new Hybrid and PHEV Vehicles Stellantis Group eDCT Assembly Plant on April 10, 2024, in Turin, Italy. 

Stellantis Eyes EV Production In Canada With China’s Leapmotor: Report

Bloomberg reported on the early stage talks on Wednesday, citing people familiar with the matter.

<ul class="summary-bullets"><li>The FDA is expected to decide on the application by June 29, as per the company.&nbsp;</li><li>The FDA in June refused to approve the company’s application citing manufacturing issues at a third-party manufacturing vendor.&nbsp;</li><li>The company is now looking to launch OLC in the third quarter.</li></ul>Shares of Unicycive Therapeutics Inc (UNCY) jumped 9% on Wednesday as retail investors contemplated the possibility of approval for the company’s Oxylanthanum carbonate.UNCY has resubmitted its application seeking the U.S. Food and Drug Administration’s approval for Oxylanthanum carbonate for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis following a previous rejection. The FDA is expected to decide on the application by June 29, as per the company.The FDA in June refused to approve the company’s application citing manufacturing issues at a third-party manufacturing vendor.The company is now looking to launch OLC in the third quarter and is continuing to strengthen its commercial infrastructure and advance market readiness initiatives in the meantime.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around UNCY jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume increased from ‘normal’ to ‘high’ levels. Over the past week, message volume rose 150%, according to Stocktwits data.A Stocktwits user predicted revenue of as much as $600 million for OLC in 2029.<stembedurl>https://www.stocktwits.com/Thrasher5699/message/649190093</stembedurl>Yet another sees 80% chances for the drug’s approval this time.<stembedurl>https://www.stocktwits.com/Cvfiore2001/message/649096819</stembedurl><h2 class="st-heading-2">Management Commentary</h2>“This year is shaping up to be pivotal for Unicycive, underscored by the U.S. Food and Drug Administration’s acceptance of our New Drug Application resubmission for OLC and the potential for approval and launch later this year,” said CEO Shalabh Gupta earlier this week. “With hyperphosphatemia still uncontrolled in nearly 75% of U.S. patients with chronic kidney disease undergoing dialysis, OLC, if approved, has the potential to offer a meaningful new treatment option characterized by a differentiated clinical profile and reduced pill burden compared to currently available phosphate binders.”Hyperphosphatemia is a condition characterized by excessively high levels of phosphate in the blood.<a href="https://stocktwits.com/symbol/UNCY">UNCY stock </a>has gained nearly 32% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/lly-stock-rallies-on-much-awaited-fda-approval-for-weight-loss-pill/cZ7Hp5ORIF5">LLY Stock Rallies On Much Awaited FDA Approval For Weight Loss Pill</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.<div class="st-video-embed" data-video-url="https://videos.stocktwits-cdn.com/hls/2026/03/26/69ee8298-8c28-42e1-b686-43e84dc29610/fq6gh7vs9vzzy7rkkx2fll5vlsu3_download.mp4" data-thumbnail-url="" data-caption="" data-summary="" data-width="" data-height="" data-orientation="horizontal" data-duration="">&nbsp;</div>

UNCY Retail Buzz Explodes 150% This Week as Traders Bet Big on Experimental Drug Approval

UNCY has resubmitted its application seeking the U.S. Food and Drug Administration’s approval for Oxylanthanum carbonate for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis. 

<ul><li>The Internal Revenue Service reportedly deployed Palantir’s data analytics platform to identify high-value audit targets using internal data.</li><li>New reporting rules require major crypto platforms to report users’ gross proceeds to the IRS starting with 2025 data.</li><li>The agency has previously used blockchain analytics and partnerships with firms like Coinbase to detect underreported crypto income.</li></ul> The Internal Revenue Service (IRS) has reportedly teamed-up with Palantir (PLTR) to flag ‘high-value’ audit targets, a move that could intensify scrutiny on crypto investors, according to ZeroHedge.The financial outlet said on Wednesday that Palantir’s Selection and Analytic Platform (SNAP) flagged in WIRED’s&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wired.com/story/documents-reveal-palantir-irs-contract-fraud-clean-energy-credits/">report</a> could potentially be extended to crypto-related audits as the IRS expands its oversight.ZeroHedge&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.zerohedge.com/ai/palantir-develops-irs-tool-flag-highest-value-audits-are-crypto-bros-next#google_vignette">added</a> that, based on last year’s tax data, major crypto platforms including Coinbase (COIN), Kraken, and PayPal (PYPL) are required to report users’ gross proceeds directly to the IRS through Form 1099-DA, a new reporting requirement for digital asset transactions. The outlet said, “It’s on-chain so they’ll never find it” is not a strategy anymore.”Form 1099-DA would make crypto audit rules similar to stock-like tax reporting, where the IRS already knows a high value transaction before a user files it.<h2 class="st-heading-2">Crypto Remains A Key Focus For Enforcement</h2>WIRED’s report noted that the IRS has previously explored methods such as contracting with companies like Coinbase to analyze crypto transaction data as part of efforts to improve audit targeting. The report emphasized that SNAP currently works only with the IRS’s internal data and does not yet incorporate external sources such as social media or third-party applications. ZeroHedge added that the IRS has historically relied on blockchain analytics and publicly available data to detect potential tax discrepancies involving digital assets. As reporting requirements tighten and analytical tools improve, crypto-related underreporting is likely to remain a key focus area for regulators, according to the blog.&nbsp;<h2 class="st-heading-2">IRS Expands Data-Driven Audit Capabilities</h2>SNAP is designed to analyze fragmented internal IRS datasets and identify cases with the greatest potential for tax recovery, according to Wired’s report. The platform is part of more than $200 million in contracts awarded by the IRS to Palantir since 2014. The system is currently being tested across areas such as clean energy credits, disaster relief claims, and gift taxes, according to the report.&nbsp; <a href="https://stocktwits.com/symbol/PLTR/sentiment">Palantir's stock</a> was up 0.99% during midday trade on Wednesday. On Stocktwits, retail sentiment around PLTR remained in the ‘bearish’ zone, while chatter around it remained ‘normal’ levels over the past day. Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/ex-pay-pal-regulator-becomes-chair-of-fellowship-pac/cZ7HAXfRIF4">Ex-PayPal Regulator Becomes Chair Of Fellowship PAC</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

A sign makes the location of the Internal Revenue Service headquarters building on March 24, 2026, in Washington, DC. (Photo by J. David Ake/Getty Images)

IRS Taps Palantir To Find 'Highest Value' Audits – Crypto Bros Could Be Next, Says ZeroHedge

The IRS has steadily increased its focus on cryptocurrency tax compliance as digital asset adoption has grown across companies.

Cryptocurrency

The IRS has steadily increased its focus on cryptocurrency tax compliance as digital asset adoption has grown across companies.


SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is experiencing significant market volatility and social media attention as the community fixates on the upcoming Artemis II mission and the company's critical role in NASA's lunar infrastructure. Investors are debating the impact of recent institutional filings and broader macroeconomic instability, while the community remains polarized between those anticipating a major breakout tied to launch success and others bracing for continued price fluctuations.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense investor scrutiny ahead of an earnings report, with community sentiment divided between speculation of a potential SpaceX-led buyout and skepticism over the company's long-term profitability. Investors are closely tracking rumors of a SpaceX IPO and potential spectrum acquisition as a key catalyst for volatility.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is facing intense scrutiny as investors weigh the stock's resilience against heightened geopolitical tensions and uncertainty surrounding the conflict in the Middle East. While community sentiment is deeply divided, ongoing debates highlight a sharp contrast between long-term confidence in the company's cloud and infrastructure dominance and short-term anxieties regarding market volatility and institutional sell-offs.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently seeing significant momentum driven by growing anticipation surrounding a potential SpaceX IPO, which investors view as a major catalyst for the entire space sector. The community is actively debating the stock's long-term infrastructure potential and institutional outlook, while sentiment remains highly positive regarding Peter Beck's leadership and the company's expanding contract backlog.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is facing intense scrutiny from investors as persistent concerns over leadership communication, the delayed update on the Helios data center project, and the stock's tendency to underperform relative to crypto sector gains dominate community discourse. While some traders view the current price action as a buying opportunity based on long-term data center potential and institutional interest, many others are expressing frustration through comparisons to previous market failures, highlighting a significant divide between institutional conviction and retail sentiment.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is currently trending as traders closely monitor technical resistance near the $10 level, while balancing persistent selling pressure from private equity firms with excitement over new defense contract wins and NASA's Artemis mission. The community remains heavily divided between long-term bulls betting on the company's space infrastructure growth and frustrated retail investors navigating high volatility and the frequent failure of recent breakout attempts.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is gaining attention as community members discuss the company's competitive position in the obesity drug market, particularly following recent phase three trial enrollment updates and perceived limitations in competitor data. Investors are closely monitoring the potential for a strategic partnership or buyout, viewing the firm's metabolic drug pipeline as a high-value asset amid broader sector-wide interest in obesity therapeutics.

Launchr is a programmable creator fee engine designed to adapt to every stage of a token’s lifecycle.  Instead of hard coded splits or one time choices, Launchr lets creators dynamically route fees in real time based on market conditions, liquidity depth, and strategy.

Launchr

LAUNCHR is capturing significant speculative attention as the community rallies around an imminent project launch, frequently associating the token with high-profile space exploration themes and viral social media momentum.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera (HBAR) is currently attracting significant retail interest as traders view current price levels as a generational accumulation opportunity ahead of anticipated regulatory clarity and institutional adoption. The community is actively debating the impact of the upcoming Digital Asset Market Clarity Act while weighing the potential for enterprise integration against concerns regarding circulating supply.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently under intense scrutiny as a major security exploit involving the Drift Protocol has triggered widespread community concern and selling pressure, overshadowing positive developments like institutional stablecoin integrations. Investors remain divided, with some actively buying the dip while others debate the network's long-term resilience against growing FUD and market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
